-
Start Preamble
Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer Liaison Group.
Date: March 24-26, 2010.
Time: March 24, 2010, 2 p.m. to 6 p.m.
Agenda: Welcome, Overview of the Cancer Genome Atlas, Expert Panel on the Cancer Genome Atlas.
Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892.
Time: March 25, 2010, 8:30 a.m. to 5:30 p.m.
Agenda: Report of the DCLG Genomics Working Group, Report on NCI Professional Judgment Budget, Board Discussion about Communicating with the Community about Genomics Research.
Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892.
Time: March 26, 2010, 8:30 a.m. to 1 p.m.
Agenda: Board Discussion about Engaging the Community around Genomics Research, Discussion with NCI Director.
Place: National Institutes of Health, Natcher Building, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Benjamin Carollo, MPA, Advocacy Relations Manager, Office of Advocacy Relations, Building 31, Room 10A30, 31 Center Drive, MSC 2580, National Cancer Institute, NIH, DHHS, Bethesda, MD 20892-2580. 301-496-0307. CAROLLOB@MAIL.NIH.GOV.
Information is also available on the Institute's/Center's home page: http://deainfo.nci.nih.gov/advisory/dclg/dclg.htm,, where an agenda and any additional information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Start SignatureDated: February 26, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-5454 Filed 3-11-10; 8:45 am]
BILLING CODE 4140-01-P
Document Information
- Effective Date:
- 3/24/2010
- Published:
- 03/12/2010
- Department:
- National Institutes of Health
- Entry Type:
- Notice
- Document Number:
- 2010-5454
- Dates:
- March 24-26, 2010.
- Pages:
- 11894-11894 (1 pages)
- PDF File:
- 2010-5454.pdf
- Supporting Documents:
- » License Agreements; Start-Up Exclusive Evaluation Option: Activators of Human Pyruvate Kinase to Treat Cancer
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: National Institute of Nursing Research
- » Meetings: National Institute of Allergy and Infectious Diseases
- » Meetings: National Eye Institute
- » Meetings: Eunice Kennedy Shriver National Institute of Child Health and Human Development
- » Meetings: Center for Scientific Review
- » Meetings: Center for Scientific Review
- » Meetings: National Institute of Environmental Health Sciences
- » Meetings: National Human Genome Research Institute